ArticleNeuroImage. Clinical2020
Image reconstruction methods affect software-aided assessment of pathologies of [
Article in NeuroImage. Clinical, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 27 citations in OpenAlex.
- Reconstruction-dependent differences in brain [18F]FDG PET: a large-scale same-acquisition comparison of Q.Clear and VUE Point FX.Annals of nuclear medicine · 2026Article
- Evaluation of regularization factor and attenuation correction method of Q.Clear reconstruction for brain PET/MR in epileptic patients.EJNMMI physics · 2026Article
- Integrated PET/MRI for the evaluation of gray matter atrophy and metabolic changes in idiopathic Parkinson's disease.Frontiers in aging neuroscience · 2026Article
- Does Q.Clear Processing Change PET Ratios? Quantitative Evidence Using BTXBrain-DAT.Brain sciences · 2025Article
- Innovations in clinical PET image reconstruction: advances in Bayesian penalized likelihood algorithm and deep learning.Annals of nuclear medicine · 2025Review
- Optimization of penalization function in Bayesian penalized likelihood reconstruction algorithm for [Physical and engineering sciences in medicine · 2024Article
- The value of PET/CT in the diagnosis and differential diagnosis of Parkinson's disease: a dual-tracer study.NPJ Parkinson's disease · 2024Article
- Impact of PET Reconstruction on Amyloid-β Quantitation in Cross-Sectional and Longitudinal Analyses.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2024Article
- Phantom and clinical evaluation of the Bayesian penalised likelihood reconstruction algorithm Q.Clear without PSF correction in amyloid PET images.EJNMMI physics · 2024Article
- Kinetic Modeling of Brain [Metabolites · 2024Article
- Characterisation of a novel [EJNMMI research · 2023Article
- Automatic lesion detection and segmentation inBiomedical engineering online · 2022Article
- Differential Diagnosis of Alzheimer Disease vs. Mild Cognitive Impairment Based on Left Temporal Lateral Lobe Hypomethabolism onDiagnostics (Basel, Switzerland) · 2022Article
- BSREM for Brain Metastasis Detection with 18F-FDG-PET/CT in Lung Cancer Patients.Journal of digital imaging · 2022Article
- Moving the goalposts while scoring-the dilemma posed by new PET technologies.European journal of nuclear medicine and molecular imaging · 2021Article
- Effect of Point Spread Function Deconvolution in Reconstruction of BrainFrontiers in medicine · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 4 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo assess how some of the new developments in brain positron emission tomography (PET) image reconstruction affect quantitative measures and software-aided assessment of pathology in patients with neurodegenerative diseases.
methodsPET data were grouped into four cohorts: prodromal Alzheimer's disease patients and controls receiving [
resultsIn controls, comparable results to the normal database were obtained with OSEM 3i/16 s 5-mm reconstruction. TOF, PSF and BSREM either increased or decreased the relative uptake difference to the normal subjects' database within the software, depending on the tracer and chosen reference area, i.e. resulting in increased absolute z-scores. Normalizing to pons and whole brain for [
conclusionsSoftware-aided assessment of patient pathologies should be used with caution when employing other image reconstruction methods than those used for acquisition of the normal database.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.